Company Overview and News
NEW YORK, April 20 (Reuters) - The potential for an intensifying trade dispute to undercut the U.S. stock market could become clearer next week when a host of multinational companies reports quarterly results that may provide a glimpse into the impact of those global tensions.
REITs and homebuilders took a leg lower this week as the 10-Year yield climbed back towards 2018 highs. Inflation expectations have picked up amid concern over tariffs, wages, and commodity prices.
The potential for an intensifying trade dispute to undercut the U.S. stock market could become clearer next week when a host of multinational companies reports quarterly results that may provide a glimpse into the impact of those global tensions.
NEW YORK (Reuters) - The potential for an intensifying trade dispute to undercut the U.S. stock market could become clearer next week when a host of multinational companies reports quarterly results that may provide a glimpse into the impact of those global tensions.
Welcome to the Prologis Q1 Earnings Conference Call. My name is Kim and I will be your operator for today's call. At this time, all participants are in listen-only mode. Later we will conduct a question-and-answer session. [Operator Instructions] Also note, this conference is being recorded. I would now like to turn the call over to Tracy Ward. Tracy, you may begin.
Prologis, Inc. (PLD - Free Report) reported first-quarter 2018 core funds from operations (FFO) per share of 80 cents, beating the Zacks Consensus Estimate of 74 cents. Results also compared favorably with the year-ago figure of 63 cents. The company experienced solid operating results and higher net promote income. Net effective rent change improved in the quarter, while period-end occupancy remained high.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Have you been eager to see how Prologis Inc. (PLD - Free Report) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this San Francisco, CA – based industrial real estate investment trust’s (REIT) earnings release this morning: A FFO Beat Prologis came out with core funds from operations ("FFO") per share of 80 cents, beating the Zacks Consensus Estimate of 74 cents.
If the rate hike in March and projections for the number of increases this year and in the next have made investors skeptical about their investment in the REIT industry, then perhaps this is the right time to reconsider. This is because total returns from REITs not only rebounded in March, but also outshined the S&P 500’s gain. Particularly, according to REIT.com, the broadest index of the U.S. REIT industry — the FTSE Nareit All REITs Index — locked in a gain of 3.
Prologis, Inc. (PLD - Free Report) is slated to report first-quarter 2018 earnings on Apr 17, before the opening bell. Last quarter, this industrial real estate investment trust (REIT) reported a better-than-expected result in terms of funds from operations (FFO) per share. Net effective rent change improved in the quarter, while period-end occupancy remained at a record high. Over the preceding four quarters, Prologis surpassed the FFO per share estimates in three occasions and met in the other.
2h - Asif
Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
as of ET